- Home
- CCEL vs RGS Comparison
CCEL vs RGS Comparison
Compare CCEL & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- RGS
- Stock Information
- Founded
- CCEL 1989
- RGS 1922
- Country
- CCEL United States
- RGS United States
- Employees
- CCEL N/A
- RGS N/A
- Industry
- CCEL Managed Health Care
- RGS Other Consumer Services
- Sector
- CCEL Health Care
- RGS Consumer Discretionary
- Exchange
- CCEL Nasdaq
- RGS Nasdaq
- Market Cap
- CCEL 53.9M
- RGS 62.4M
- IPO Year
- CCEL 1997
- RGS 1991
- Fundamental
- Price
- CCEL $6.49
- RGS $26.99
- Analyst Decision
- CCEL
- RGS
- Analyst Count
- CCEL 0
- RGS 0
- Target Price
- CCEL N/A
- RGS N/A
- AVG Volume (30 Days)
- CCEL 3.9K
- RGS 62.8K
- Earning Date
- CCEL 10-18-2024
- RGS 10-30-2024
- Dividend Yield
- CCEL N/A
- RGS N/A
- EPS Growth
- CCEL N/A
- RGS N/A
- EPS
- CCEL N/A
- RGS 38.34
- Revenue
- CCEL $31,641,636.00
- RGS $202,982,000.00
- Revenue This Year
- CCEL $3.70
- RGS N/A
- Revenue Next Year
- CCEL $10.57
- RGS N/A
- P/E Ratio
- CCEL N/A
- RGS $0.67
- Revenue Growth
- CCEL 1.93
- RGS N/A
- 52 Week Low
- CCEL $3.67
- RGS $3.87
- 52 Week High
- CCEL $9.50
- RGS $35.50
- Technical
- Relative Strength Index (RSI)
- CCEL 50.57
- RGS 56.13
- Support Level
- CCEL $6.29
- RGS $25.02
- Resistance Level
- CCEL $6.80
- RGS $27.85
- Average True Range (ATR)
- CCEL 0.33
- RGS 2.06
- MACD
- CCEL 0.03
- RGS -0.02
- Stochastic Oscillator
- CCEL 32.04
- RGS 63.48
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
About RGS Regis Corporation
Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.